Lv11
48 积分 2022-08-03 加入
Physiologically Based Pharmacokinetic Modeling of Elexacaftor-Tezacaftor-Ivacaftor in Adults and Pediatric People with Cystic Fibrosis: Exploring Brain Exposure and Neuropsychiatric Adverse Events
2天前
已完结
Finding a needle in the haystack: ADME and pharmacokinetics/pharmacodynamics characterization and optimization towards orally available bifunctional protein degraders
1个月前
已完结
Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC Degrader
1个月前
已完结
Preclinical translational physiologically based pharmacokinetic modeling for predicting human pharmacokinetics of proteolysis targeting chimeras: Case studies of vepdegestrant (ARV-471) and bavdegalutamide (ARV-110)
1个月前
已完结
Pulmonary Dissolution of Poorly Soluble Compounds Studied in an ex Vivo Rat Lung Model
1个月前
已完结
Ampicillin Pharmacokinetics During First Week of Life in Preterm and Term Neonates
4个月前
已完结
Overview of Quantitative Clinical Pharmacology for T-Cell Engaging Bispecific Antibodies
5个月前
已完结
Quantitative characterization of drug metabolism and transport alterations in obesity with metabolic fatty liver disease: A physiologically based pharmacokinetic modelling approach
5个月前
已关闭
Physiologically-Based Pharmacokinetic Modeling and Dosing Optimization of Cefotaxime in Preterm and Term Neonates
6个月前
已完结
Physiologically Based Pharmacokinetic Model of Cefotaxime in Patients with Impaired Renal Function
7个月前
已完结
皖公网安备34019202002308
